Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again.

Bucktrout SL, Bluestone JA, Ramsdell F.

Genome Med. 2018 Oct 31;10(1):79. doi: 10.1186/s13073-018-0588-4. Review.

2.

Pillars Article: An Essential Role for Scurfin in CD4+CD25+ T Regulatory Cells. Nat. Immunol. 2003. 4: 337-342.

Khattri R, Cox T, Yasayko SA, Ramsdell F.

J Immunol. 2017 Feb 1;198(3):993-998. No abstract available.

3.

FOXP3 and scurfy: how it all began.

Ramsdell F, Ziegler SF.

Nat Rev Immunol. 2014 May;14(5):343-9. doi: 10.1038/nri3650. Epub 2014 Apr 11. Review.

PMID:
24722479
4.

Vstm3 is a member of the CD28 family and an important modulator of T-cell function.

Levin SD, Taft DW, Brandt CS, Bucher C, Howard ED, Chadwick EM, Johnston J, Hammond A, Bontadelli K, Ardourel D, Hebb L, Wolf A, Bukowski TR, Rixon MW, Kuijper JL, Ostrander CD, West JW, Bilsborough J, Fox B, Gao Z, Xu W, Ramsdell F, Blazar BR, Lewis KE.

Eur J Immunol. 2011 Apr;41(4):902-15. doi: 10.1002/eji.201041136. Epub 2011 Mar 18.

5.

A point mutation in the murine Hem1 gene reveals an essential role for Hematopoietic protein 1 in lymphopoiesis and innate immunity.

Park H, Staehling-Hampton K, Appleby MW, Brunkow ME, Habib T, Zhang Y, Ramsdell F, Liggitt HD, Freie B, Tsang M, Carlson G, Friend S, Frevert C, Iritani BM.

J Exp Med. 2008 Nov 24;205(12):2899-913. doi: 10.1084/jem.20080340. Epub 2008 Nov 17.

6.

Scurfy, the Foxp3 locus, and the molecular basis of peripheral tolerance.

Appleby MW, Ramsdell F.

Curr Top Microbiol Immunol. 2008;321:151-68. Review.

PMID:
18727491
7.

In vitro systems for the study of T cell development: fetal thymus organ culture and OP9-DL1 cell coculture.

Ramsdell F, Zúñiga-Pflücker JC, Takahama Y.

Curr Protoc Immunol. 2006 Mar;Chapter 3:Unit 3.18. doi: 10.1002/0471142735.im0318s71.

PMID:
18432973
8.

Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis.

Uhlig HH, Coombes J, Mottet C, Izcue A, Thompson C, Fanger A, Tannapfel A, Fontenot JD, Ramsdell F, Powrie F.

J Immunol. 2006 Nov 1;177(9):5852-60.

9.

Splice variants of human FOXP3 are functional inhibitors of human CD4+ T-cell activation.

Smith EL, Finney HM, Nesbitt AM, Ramsdell F, Robinson MK.

Immunology. 2006 Oct;119(2):203-11.

10.

Dynamic regulation of FoxP3 expression controls the balance between CD4+ T cell activation and cell death.

Kasprowicz DJ, Droin N, Soper DM, Ramsdell F, Green DR, Ziegler SF.

Eur J Immunol. 2005 Dec;35(12):3424-32.

11.

A novel mutation in CD83 results in the development of a unique population of CD4+ T cells.

García-Martínez LF, Appleby MW, Staehling-Hampton K, Andrews DM, Chen Y, McEuen M, Tang P, Rhinehart RL, Proll S, Paeper B, Brunkow ME, Grandea AG 3rd, Howard ED, Walker DE, Charmley P, Jonas M, Shaw S, Latham JA, Ramsdell F.

J Immunol. 2004 Sep 1;173(5):2995-3001.

12.

Transcription factors in autoimmunity.

Ramsdell F, Ziegler SF.

Curr Opin Immunol. 2003 Dec;15(6):718-24. Review.

PMID:
14630208
13.

Foxp3 and natural regulatory T cells: key to a cell lineage?

Ramsdell F.

Immunity. 2003 Aug;19(2):165-8. Review.

14.

A forward-genetic approach for analysis of the immune system.

Appleby MW, Ramsdell F.

Nat Rev Immunol. 2003 Jun;3(6):463-71. Review.

PMID:
12776206
15.

An essential role for Scurfin in CD4+CD25+ T regulatory cells.

Khattri R, Cox T, Yasayko SA, Ramsdell F.

Nat Immunol. 2003 Apr;4(4):337-42. Epub 2003 Mar 3.

PMID:
12612581
16.

A mouse strain defective for alphabeta versus gammadelta T cell lineage commitment.

Mertsching E, Wurster AL, Katayama C, Esko J, Ramsdell F, Marth JD, Hedrick SM.

Int Immunol. 2002 Sep;14(9):1039-53.

PMID:
12202401
17.

Benzobicyclooctanes as novel inhibitors of TNF-alpha signaling.

Jackson RW, Gelinas R, Baughman TA, Cox T, Howbert JJ, Kucera KA, Latham JA, Ramsdell F, Singh D, Darwish IS.

Bioorg Med Chem Lett. 2002 Apr 8;12(7):1093-7.

PMID:
11909725
18.

The amount of scurfin protein determines peripheral T cell number and responsiveness.

Khattri R, Kasprowicz D, Cox T, Mortrud M, Appleby MW, Brunkow ME, Ziegler SF, Ramsdell F.

J Immunol. 2001 Dec 1;167(11):6312-20.

19.

A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA-->AAUGAA) leads to the IPEX syndrome.

Bennett CL, Brunkow ME, Ramsdell F, O'Briant KC, Zhu Q, Fuleihan RL, Shigeoka AO, Ochs HD, Chance PF.

Immunogenetics. 2001 Aug;53(6):435-9.

PMID:
11685453
20.

Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation.

Schubert LA, Jeffery E, Zhang Y, Ramsdell F, Ziegler SF.

J Biol Chem. 2001 Oct 5;276(40):37672-9. Epub 2001 Aug 1.

21.

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse.

Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F.

Nat Genet. 2001 Jan;27(1):68-73.

PMID:
11138001
22.

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD.

Nat Genet. 2001 Jan;27(1):20-1.

PMID:
11137993
23.

X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.

Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy-Lahad E, Mazzella M, Goulet O, Perroni L, Bricarelli FD, Byrne G, McEuen M, Proll S, Appleby M, Brunkow ME.

Nat Genet. 2001 Jan;27(1):18-20.

PMID:
11137992
24.

Cellular and molecular characterization of the scurfy mouse mutant.

Clark LB, Appleby MW, Brunkow ME, Wilkinson JE, Ziegler SF, Ramsdell F.

J Immunol. 1999 Mar 1;162(5):2546-54.

25.

Immunoregulatory effects of Fas-mediated signalling.

Lynch DH, Alderson MR, Ramsdell F.

J Cell Biochem. 1996 Jan;60(1):39-46. Review. No abstract available.

PMID:
8825414
26.

Fas and FasL in the homeostatic regulation of immune responses.

Lynch DH, Ramsdell F, Alderson MR.

Immunol Today. 1995 Dec;16(12):569-74. Review.

PMID:
8579749
27.

Fas ligand mediates activation-induced cell death in human T lymphocytes.

Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH.

J Exp Med. 1995 Jan 1;181(1):71-7.

28.

Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.

Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CB, Meyer JD, Davison BL.

J Exp Med. 1994 Nov 1;180(5):1955-60.

29.

Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death.

Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy MK, Lynch DH.

Int Immunol. 1994 Oct;6(10):1545-53.

PMID:
7530039
30.

Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34.

Baum PR, Gayle RB 3rd, Ramsdell F, Srinivasan S, Sorensen RA, Watson ML, Seldin MF, Baker E, Sutherland GR, Clifford KN, et al.

EMBO J. 1994 Sep 1;13(17):3992-4001.

31.

The activation antigen CD69.

Ziegler SF, Ramsdell F, Alderson MR.

Stem Cells. 1994 Sep;12(5):456-65. Review.

PMID:
7804122
32.

Identification of OX40 ligand and preliminary characterization of its activities on OX40 receptor.

Baum PR, Gayle RB 3rd, Ramsdell F, Srinivasan S, Sorensen RA, Watson ML, Seldin MF, Clifford KN, Grabstein K, Alderson MR, et al.

Circ Shock. 1994 Sep;44(1):30-4. No abstract available.

PMID:
7704935
33.

Recombinant CD40 ligand exerts potent biologic effects on T cells.

Fanslow WC, Clifford KN, Seaman M, Alderson MR, Spriggs MK, Armitage RJ, Ramsdell F.

J Immunol. 1994 May 1;152(9):4262-9.

PMID:
7908915
34.

gld/gld mice are unable to express a functional ligand for Fas.

Ramsdell F, Seaman MS, Miller RE, Tough TW, Alderson MR, Lynch DH.

Eur J Immunol. 1994 Apr;24(4):928-33.

PMID:
7512035
35.

CD40 ligand acts as a costimulatory signal for neonatal thymic gamma delta T cells.

Ramsdell F, Seaman MS, Clifford KN, Fanslow WC.

J Immunol. 1994 Mar 1;152(5):2190-7.

PMID:
7510740
36.

The mouse CD69 gene. Structure, expression, and mapping to the NK gene complex.

Ziegler SF, Levin SD, Johnson L, Copeland NG, Gilbert DJ, Jenkins NA, Baker E, Sutherland GR, Feldhaus AL, Ramsdell F.

J Immunol. 1994 Feb 1;152(3):1228-36.

PMID:
8301128
37.

TNF abrogates the response of the CT.4S cell line to IL-4.

Ramsdell F, Picha KS, Seaman MS, Kennedy MK.

J Immunol Methods. 1994 Jan 3;167(1-2):299-301. No abstract available.

PMID:
8308285
38.

T-cell tolerance.

Fowlkes BJ, Ramsdell F.

Curr Opin Immunol. 1993 Dec;5(6):873-9. Review.

PMID:
8297519
39.

Fas transduces activation signals in normal human T lymphocytes.

Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH.

J Exp Med. 1993 Dec 1;178(6):2231-5.

40.

Spontaneous and inducible epidermal hyperplasia in transgenic mice expressing HIV-1 Nef.

Dickie P, Ramsdell F, Notkins AL, Venkatesan S.

Virology. 1993 Nov;197(1):431-8.

PMID:
8212579
41.

CD40 ligand is a T cell growth factor.

Armitage RJ, Tough TW, Macduff BM, Fanslow WC, Spriggs MK, Ramsdell F, Alderson MR.

Eur J Immunol. 1993 Sep;23(9):2326-31.

PMID:
7690330
42.

Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigens.

Ziegler SF, Ramsdell F, Hjerrild KA, Armitage RJ, Grabstein KH, Hennen KB, Farrah T, Fanslow WC, Shevach EM, Alderson MR.

Eur J Immunol. 1993 Jul;23(7):1643-8.

PMID:
8100776
43.

An approach to development of specific T-lymphocyte lines by use of preprocessed antigens in Plasmodium vinckei vinckei murine malaria.

Wasserman GM, Kumar S, Ahlers J, Ramsdell F, Berzofsky JA, Miller LH.

Infect Immun. 1993 May;61(5):1958-63.

44.

A self-reactive T cell population that is not subject to negative selection.

Robey EA, Ramsdell F, Gordon JW, Mamalaki C, Kioussis D, Youn HJ, Gottlieb PD, Axel R, Fowlkes BJ.

Int Immunol. 1992 Sep;4(9):969-74.

PMID:
1390439
45.

Maintenance of in vivo tolerance by persistence of antigen.

Ramsdell F, Fowlkes BJ.

Science. 1992 Aug 21;257(5073):1130-4.

PMID:
1354889
46.

The level of CD8 expression can determine the outcome of thymic selection.

Robey EA, Ramsdell F, Kioussis D, Sha W, Loh D, Axel R, Fowlkes BJ.

Cell. 1992 Jun 26;69(7):1089-96.

PMID:
1617724
47.

The majority of CD4+8- thymocytes are functionally immature.

Ramsdell F, Jenkins M, Dinh Q, Fowlkes BJ.

J Immunol. 1991 Sep 15;147(6):1779-85.

PMID:
1679836
48.

Expression of CD4 in transgenic mice alters the specificity of CD8 cells for allogeneic major histocompatibility complex.

Robey E, Ramsdell F, Elliott J, Raulet D, Kioussis D, Axel R, Fowlkes BJ.

Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):608-12.

49.

Thymic selection in CD8 transgenic mice supports an instructive model for commitment to a CD4 or CD8 lineage.

Robey EA, Fowlkes BJ, Gordon JW, Kioussis D, von Boehmer H, Ramsdell F, Axel R.

Cell. 1991 Jan 11;64(1):99-107.

PMID:
1898873
50.

Thymic mechanisms for inducing tolerance to Mls.

Ramsdell F, Lantz T, Hausman F, Fowlkes BJ.

Adv Exp Med Biol. 1991;292:139-47. Review. No abstract available.

PMID:
1835260

Supplemental Content

Loading ...
Support Center